UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Infosys
INFY
|
+$767M |
| 2 |
Amazon
AMZN
|
+$288M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$287M |
| 4 |
NVIDIA
NVDA
|
+$259M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$249M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$347M |
| 2 |
TWTR
Twitter, Inc.
TWTR
|
+$316M |
| 3 |
Citigroup
C
|
+$269M |
| 4 |
Charter Communications
CHTR
|
+$229M |
| 5 |
NetEase
NTES
|
+$211M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.35% |
| 2 | Consumer Discretionary | 13.14% |
| 3 | Financials | 12.19% |
| 4 | Healthcare | 12.04% |
| 5 | Communication Services | 9.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1201
Emergent Biosolutions
EBS
$231M
| $6.17M | ﹤0.01% |
66,406
-4,395
| -6% | -$450K |
|
1202
BlackLine
BL
$1.69B
| $6.15M | ﹤0.01% |
56,738
+1,155
| +2% | +$144K |
|
1203
Yeti Holdings
YETI
$3.9B
| $6.14M | ﹤0.01% |
85,035
+2,691
| +3% | +$192K |
|
|
UNVR
1204
DELISTED
Univar Solutions Inc.
UNVR
| $6.14M | ﹤0.01% |
284,954
-4,318
| -1% | -$88.4K |
|
1205
Helen of Troy
HELE
$673M
| $6.12M | ﹤0.01% |
29,052
-506
| -2% | -$114K |
|
1206
Boyd Gaming
BYD
$5.92B
| $6.11M | ﹤0.01% |
103,645
-2,606
| -2% | -$142K |
|
1207
New Jersey Resources
NJR
$5.48B
| $6.1M | ﹤0.01% |
152,967
+1,413
| +0.9% | +$53.9K |
|
1208
Arrowhead Research
ARWR
$12.4B
| $6.06M | ﹤0.01% |
91,461
-26,135
| -22% | -$2.03M |
|
|
RDFN
1209
DELISTED
Redfin
RDFN
| $6.03M | ﹤0.01% |
90,494
+4,266
| +5% | +$325K |
|
1210
Spectrum Brands
SPB
$2.01B
| $6M | ﹤0.01% |
70,637
-2,335
| -3% | -$190K |
|
1211
Xenon Pharmaceuticals
XENE
$6.11B
| $5.99M | ﹤0.01% |
334,741
-3,090
| -0.9% | -$52.4K |
|
1212
Adient
ADNT
$1.45B
| $5.98M | ﹤0.01% |
135,236
-20,361
| -13% | -$769K |
|
1213
Varonis Systems
VRNS
$5.03B
| $5.98M | ﹤0.01% |
116,394
+3,027
| +3% | +$179K |
|
1214
Beyond Meat
BYND
$279M
| $5.88M | ﹤0.01% |
45,213
-7,699
| -15% | -$1.13M |
|
1215
Columbia Sportswear
COLM
$2.91B
| $5.88M | ﹤0.01% |
55,690
+283
| +0.5% | +$28K |
|
|
DHC
1216
Diversified Healthcare Trust
DHC
$2.04B
| $5.88M | ﹤0.01% |
1,230,292
-1,746
| -0.1% | -$8.04K |
|
1217
Radian Group
RDN
$4.91B
| $5.87M | ﹤0.01% |
252,309
-2,012
| -0.8% | -$42.8K |
|
1218
Commercial Metals
CMC
$8.19B
| $5.84M | ﹤0.01% |
189,453
-2,219
| -1% | -$54.9K |
|
|
WCC
1219
WESCO International
WCC
$18B
| $5.8M | ﹤0.01% |
67,008
-887
| -1% | -$74.7K |
|
1220
SiteOne Landscape Supply
SITE
$4.41B
| $5.8M | ﹤0.01% |
33,957
-5,111
| -13% | -$848K |
|
|
CCMP
1221
DELISTED
CMC Materials, Inc. Common Stock
CCMP
| $5.8M | ﹤0.01% |
+32,794
| New | +$5.44M |
|
|
ILPT
1222
Industrial Logistics Properties Trust
ILPT
$576M
| $5.79M | ﹤0.01% |
250,280
+6,798
| +3% | +$152K |
|
1223
HealthEquity
HQY
$8.95B
| $5.77M | ﹤0.01% |
84,799
+705
| +0.8% | +$55.4K |
|
1224
Synaptics
SYNA
$4.2B
| $5.74M | ﹤0.01% |
42,378
-2,019
| -5% | -$246K |
|
|
ADVM
1225
DELISTED
Adverum Biotechnologies
ADVM
| $5.73M | ﹤0.01% |
58,127
+146
| +0.3% | +$17.5K |
|
Similar funds
UBS AM's Q1 2021 Portfolio in Review
As of Q1 2021, UBS AM held 2,645 positions worth $226B, up 6% from $213B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Trading was light in Q1 2021: portfolio turnover was 4.9%. UBS AM opened 86 new positions and exited 44, leaving the 2,645-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 25% a quarter earlier, followed by Consumer Discretionary and Financials.
- UBS AM's largest Q1 2021 buy was Seagen Inc. Common Stock: 966,114 shares worth $134M.
- UBS AM added most to Infosys in Q1 2021, an estimated $767M increase.
- UBS AM's biggest Q1 2021 reduction was Alibaba, cutting an estimated $347M.
- UBS AM fully exited Lumen in Q1 2021, selling an estimated $45.5M.
- UBS AM's ten largest holdings make up 22% of its $226B portfolio in Q1 2021.
- UBS AM opened 86 new positions and closed 44 in Q1 2021.
- UBS AM's portfolio value rose 6% quarter-over-quarter to $226B.
Based on UBS AM's 13F filing for Q1 2021, filed 14 May 2021.